3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) - 6- (pyrimidin-4-yl) pyrimidin-4 (3H) -one as tau protein kinase inhibitor
Details for Australian Patent Application No. 2008297814 (hide)
International Classifications
Event Publications
22 April 2010 PCT application entered the National Phase
PCT publication WO2009/035159 Priority application(s): WO2009/035159
15 July 2010 Amendment Made
The nature of the amendment is: Amend the invention title to read 3-Methyl-2- ( (2S) -2- (4- (3-Methyl-1, 2, 4-Oxadiazol-5-YL) phenyl) morpholino) -6- (pyrimidin-4-yl) Pyrimidin4 (3H) -one as tau protein kinase inhibitor
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser